Difference between revisions of "Dosulepine-vortioxetine"

From Psychiatrienet
Jump to: navigation, search
(Created page with 'File:Empty.jpg')
 
Line 1: Line 1:
[[File:Empty.jpg]]
+
{{Drugswitch
 +
| from = agomelatine
 +
| to = vortioxetine
 +
| stop = | stop =
 +
* '''Before day 1:''' gradually reduce dosage of dosulepine to a maximum of 75 mg/day.
 +
* '''Day 1:''' reduce dosage of dosulepine to 50 mg/day.
 +
* '''Day 3:''' reduce dosage of dosulepine to 25 mg/day.
 +
* '''Day 7:''' stop dosulepine
 +
| start =
 +
* A wash-out period is not necessary.
 +
* Start administration of vortioxetine the next day in a dosage of 10 mg/day.
 +
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.
 +
}}

Revision as of 13:48, 4 March 2015

Agomelatine
Type Antidepressant
Group other
links
ATC-code N06AX22
EMEA valdoxan
PubChem 82148
PubMed Agomelatine
Kompas (Dutch) Agomelatine
Wikipedia Agomelatine
Vortioxetine
Type Antidepressant
Group SMS
links
Medscape Vortioxetine
PubChem 9966051
PubMed Vortioxetine
Kompas (Dutch) Vortioxetine
Wikipedia Vortioxetine

Switch medication from agomelatine to vortioxetine.[1] [2]

Nietinrijdenbord.png Stop agomelatine
  • Before day 1: gradually reduce dosage of dosulepine to a maximum of 75 mg/day.
  • Day 1: reduce dosage of dosulepine to 50 mg/day.
  • Day 3: reduce dosage of dosulepine to 25 mg/day.
  • Day 7: stop dosulepine
Eenrichtingbord.png Start vortioxetine
  • A wash-out period is not necessary.
  • Start administration of vortioxetine the next day in a dosage of 10 mg/day.
  • Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.


  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.